Accelerate your program with integrated CRO, Process R&D and CDMO services designed to deliver faster, reliable results.
PHT offers phase-appropriate customized services and delivers end-to-end solutions across the drug development cycle. As an integrated CDMO, we provide contract development and manufacturing services for small molecule pharma intermediates, regulatory starting materials and APIs.
Our core capabilities span custom synthesis, process research and development, analytical development, scale-up and cGMP manufacturing.
With a focus on scientific excellence and innovation, collaboration, and transparent communication, PHT Pharma operates as an extension of your team, enabling faster decision-making, streamlined execution, and successful project outcomes.
PHT Pharma’s CRO division provides high-quality scientific research support designed to accelerate early-stage discovery and development. Our capabilities include:
With deep expertise in route scouting, synthetic development, processes, analytical R&D, impurity profiling, and method development, our team delivers data-driven insights, reliable scientific output and regulatory-aligned documentation. Collaboration, confidentiality and responsiveness define our approach, enabling faster decisions and seamless project continuity.
Innovation and scientific rigor guide every project. By converting complex challenges into practical, scalable and economically viable solutions, our PR&D team strengthens program success and regulatory-ready development.
PHT Pharma offers integrated CDMO capabilities that transform promising chemical innovations into commercially viable pharmaceutical products. With a cGMP-compliant manufacturing facility in China (previously inspected by the USFDA) and global sourcing capabilities, we deliver:
Scalable production from laboratory through pilot to commercial manufacturing, supported by seamless technology transfer and fully optimized scale-up processes, our CDMO team is focused on delivering robust, reproducible outcomes with on-time, in-full supply of materials to agreed specifications.
PHT Pharma possesses broad manufacturing expertise, which includes the use of flow chemistry and surfactants, metal catalyzed reactions, hydrogenation, organometallic chemistry, halogenation, Grignard chemistry, Suzuki couplings, cryogenic and high temperature reactions, all supported by efficient project management and transparent communications.
Our flexible CDMO model ensures operational control, regulatory compliance and minimized time-to-market, making PHT a dependable partner throughout the manufacturing life cycle.
